Pharm Exec3d
FDA Approves Bavarian Nordic’s Chikungunya Vaccine Vimkunya
The FDA has approved Bavarian Nordic’s Vimkunya, the first virus-like particle (VLP) chikungunya vaccine for patients over 12 years of age. According to the company, approval was based on strong ...
The Financial Express7d
FDA gives nod to first rapid-acting insulin biosimilar for diabetes treatment
The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
GlobalData on MSN5d
Bavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teens
Bavarian Nordic sets up a bout with Valneva’s Ixchiq, the former’s Vimkunya already having an edge in population reach.
Yahoo Finance8d
Subtle Medical's SubtleHD™ Awarded FDA Clearance, Setting a New Benchmark for MRI Image Quality and Speed
This approval marks the official ... to generate orthogonal reformats. (FDA-Cleared) Subtle Medical was the first to market with third-party AI-powered image enhancement software solutions with ...